http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CO-2018002354-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a73cee5001ad08339ae751c10d9abf71
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4453
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4465
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-32
filingDate 2018-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c22464a86b13a64127c99b30486261ee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1ab2f5c834379580e9aa8229139d1d75
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d9f32a7c8d6006eba9ebbba433810b32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d49f1edd1cf04dd9d39b673304d86e9f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_34d51332ea8d3f108c08050d7f50c355
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dea50d83b26f168881a0a57590e2c01a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_384ad06e927b85322b17834f7861f3ce
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0dfca77d406c01cbb9cc125388241f87
publicationDate 2018-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CO-2018002354-A2
titleOfInvention Salts of 1 - ((4- (methoxymethyl) -4 - ((((1r, 2s) -2-phenylcyclopropylamino) methyl) piperidin-1-yl) methyl) cyclobutanecarboxylic acid as inhibitors of lsd1
abstract The present description refers to 1 - {[4- (methoxymethyl) -4 - ({[(1R, 2S) -2-phenylcyclopropyl] amino} methyl) piperidin-1-yl] methyl} cyclobutanecarboxylic acid tosylate salts, methods for its preparation and intermediates in its preparation, which are useful in the treatment of diseases associated with or mediated by LSD1, such as cancer.
priorityDate 2015-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID126569830
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454604136
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425115158
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394313
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19494
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393790

Total number of triples: 36.